Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Why did Iran bomb Dubai? A Middle East expert explains the regional alliances at play 
Trump Says U.S. Combat Operations in Iran Will Continue Until Objectives Are Met 
Marco Rubio to Brief Congress After U.S.-Israeli Strikes on Iran 
Trump Says U.S. Attacks on Iran Will Continue, Warns of More American Casualties 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
U.S. Lawmakers Question Trump’s Iran Strategy After Joint U.S.-Israeli Strikes 
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s 
Netanyahu Suggests Iran’s Supreme Leader Khamenei May Have Been Killed in Israeli-U.S. Strikes 
U.S. Deploys Tomahawks, B-2 Bombers, F-35 Jets and AI Tools in Operation Epic Fury Against Iran 
Trump Announces U.S. Strikes on Iran Navy as Conflict Escalates 
Russia Signals Openness to U.S. Security Guarantees for Ukraine at Geneva Peace Talks 
U.S. President Donald Trump asked the help of American pharmaceutical firms that are currently working on experimental COVID-19 treatments to offer their drugs to Boris Johnson. The British Prime Minister has been moved to the I.C.U. after his coronavirus symptoms worsened.
“I’ve asked two of the leading companies,” Donald Trump said during a press conference, The Guardian reported. “They’ve come with the solutions and just have done incredible jobs – and I’ve asked him to contact London immediately.”
Trump said that the drugs are already in London and ready for use. “They’ve really advanced therapeutics … and they have arrived in London already,” the U.S. President said. “The London office has whatever they need. We’ll see if we can be of help. We’ve contacted all of Boris’s doctors, and we’ll see what is going to take place, but they are ready to go.”
The President did not specifically mention the name of the drugs or the pharmaceutical companies that made them. However, The Guardian noted that Trump had an earlier conference with the heads of biotech and pharmaceutical firms Amgen, Genetech, Gilead and Regeneron, pointed out that
However, Trump revealed that it’s still not certain if Boris Johnson would opt for the experimental treatments. “They’ve had meetings with the doctors, and we’ll see whether or not they want to go that route,” he said. “But when you’re in intensive care it’s a big deal. So they’re there and they’re ready.”
Donald Trump expressed sadness over what happened to his British counterpart, whom he considers to be one of his closest allies. “We’re very saddened to hear that he was taken into intensive care this afternoon, a little while ago, and Americans are all praying for his recovery,” Trump said. “He’s been a really good friend. He’s been really something very special: strong, resolute, doesn’t quit, doesn’t give up.”
Johnson has been moved to intensive care on Monday afternoon after his symptoms worsened, according to BBC. “Over the course of [Monday] afternoon, the condition of the prime minister has worsened and, on the advice of his medical team, he has been moved to the intensive care unit at the hospital,” a statement from No. 10 Downing Street reads.
